Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1670-1676

  Min, Ji Kim ^a,b   Jardel, Claude ^a,c   Barthélémy, Cyrille ^a   Jan, Véronique ^a,d   Bastard, Jean Philippe ^a,d   Fillaut Chapin, Sandrine ^c   Houry, Sydney ^d   Capeau, Jacqueline ^a,b,d   Lombés, Anne ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MALATE DEHYDROGENASE; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GABPA; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR PPRC1;

ADIPOSE TISSUE; ADULT; AGED; APOPTOSIS; ARTICLE; BIOGENESIS; BODY MASS; CORRELATION ANALYSIS; COX4I1 GENE; DNA CONTENT; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENETIC CORRELATION; GENETIC TRANSCRIPTION; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL DNA DEPLETION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SPECTROPHOTOMETRY; TRANSCRIPTION REGULATION; UCP2 GENE; UPREGULATION;

ADIPOSE TISSUE; ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42949105970     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01449-07     Document Type: Article

References (51)

1. Auré, K., G. Fayet, J. P. Leroy, E. Lacène, N. B. Romero, and A. Lombès. 2006. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Brain 129:1249-1259.
2. Babior, B. M., J. D. Lambeth, and W. Nauseef. 2002. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397:342-344.
3. Barthélémy, C., H. Ogier de Baulny, J. Diaz, M. A. Cheval, P. Frachon, N. Romero, F. Goutieres, M. Fardeau, and A. Lombès. 2001. Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. Ann. Neurol. 49:607-617.
4. Bastard, J. P., M. Caron, H. Vidal, V. Jan, M. Auclair, C. Vigoureux, J. Luboinski, M. Laville, M. Maachi, P. M. Girard, W. Rozenbaum, P. Levan, and J. Capeau. 2002. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359:1026-1031.
5. Carr, A., and D. A. Cooper. 2000. Adverse effects of antiretroviral therapy. Lancet 356:1423-1430.
6. Carriere, A., M. C. Carmona, Y. Fernandez, M. Rigoulet, R. H. Wenger, L. Penicaud, and L. Casteilla. 2004. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J. Biol. Chem. 279:40462-40469.
7. Cherry, C. L., M. E. Gahan, J. C. McArthur, S. R. Lewin, J. F. Hoy, and S. L. Wesselingh. 2002. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J. Acquir. Immune Defic. Syndr. 30:271-277.
8. Desagher, S., and J. C. Martinou. 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369-377.
9. Domingo, P., X. Matias-Guiu, R. M. Pujol, E. Francia, E. Lagarda, M. A. Sambeat, and G. Vazquez. 1999. Subcutaneous adipocyte apoptosis in HIV-I protease inhibitor-associated lipodystrophy. AIDS 13:2261-2267.
10. Finck, B. N., and D. P. Kelly. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Investig. 116:615-622.
11. Furukawa, S., T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 114:1752-1761.
12. Galluzzi, L., M. Pinti, G. Guaraldi, C. Mussini, L. Troiano, E. Roat, C. Giovenzana, E. Nemes, M. Nasi, G. Orlando, P. Salomoni, and A. Cossarizza. 2005. Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir. Ther. 10(Suppl. 2):M91-M99.
13. Garesse, R., and C. G. Vallejo. 2001. Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. Gene 263:1-16.
14. Gougeon, M. L., L. Penicaud, B. Fromenty, P. Leclercq, J. P. Viard, and J. Capeau. 2004. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir. Ther. 9:161-177.
15. Hammond, E., D. Nolan, I. James, C. Metcalf, and S. Mallal. 2004. Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy. AIDS 18:815-817.
16. Hudson, G., and P. F. Chinnery. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15(Spec. No. 2):R244-R252.
17. Igoudjil, A., A. Abbey-Toby, K. Begriche, A. Grodet, K. Chataigner, G. Peytavin, M. Maachi, M. Colin, M. A. Robin, P. Letteron, G. Feldmann, D. Pessayre, and B. Fromenty. 2007. High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice. Antivir. Ther. 12:389-400.
18. Jan, V., P. Cervera, M. Maachi, M. Baudrimont, M. Kim, H. Vidal, P. M. Girard, P. Levan, W. Rozenbaum, A. Lombes, J. Capeau, and J. P. Bastard. 2004. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir. Ther. 9:555-564.
19. Joly, V., P. Flandre, V. Meiffredy, N. Leturque, M. Harel, J. P. Aboulker, and P. Yeni. 2002. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS 16:2447-2454.
20. Kannisto, K., J. Sutinen, E. Korsheninnikova, R. M. Fisher, E. Ehrenborg, K. Gertow, A. Virkamaki, T. Nyman, H. Vidal, A. Hamsten, and H. Yki-Jarvinen. 2003. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma coactivator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 17:1753-1762.
21. Kujoth, G. C., A. Hiona, T. D. Pugh, S. Someya, K. Panzer, S. E. Wohlgemuth, T. Hofer, A. Y. Seo, R. Sullivan, W. A. Jobling, J. D. Morrow, H. Van Remmen, J. M. Sedivy, T. Yamasoba, M. Tanokura, R. Weindruch, C. Leeuwenburgh, and T. A. Prolla. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:481-484.
22. Labarthe, F., D. Dobbelaere, L. Devisme, A. De Muret, C. Jardel, J. W. Taanman, F. Gottrand, and A. Lombès. 2005. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J. Hepatol. 43:333-341.
23. Lagathu, C., B. Eustace, M. Prot, D. Frantz, Y. Gu, J. P. Bastard, M. Maachi, S. Azoulay, M. Briggs, M. Caron, and J. Capeau. 2007. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir. Ther. 12:489-500.
24. Lewis, W., B. J. Day, and W. C. Copeland. 2003. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat. Rev. Drug Discov. 2:812-822.
25. Lloreta, J., P. Domingo, R. M. Pujol, J. A. Arroyo, N. Baixeras, X. Matias-Guiu, M. Gilaberte, M. A. Sambeat, and S. Serrano. 2002. Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy. Virchows Arch. 441:599-604.
26. Lombès, A., J. R. Mendell, H. Nakase, R. J. Barohn, E. Bonilla, M. Zeviani, A. J. Yates, J. Omerza, T. L. Gales, K. Nakahara, et al. 1989. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann. Neurol. 26:20-33.
27. 2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24:1844-1854.
28. Mallon, P. W., P. Unemori, R. Sedwell, A. Morey, M. Rafferty, K. Williams, D. Chisholm, K. Samaras, S. Emery, A. Kelleher, D. A. Cooper, and A. Carr. 2005. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J. Infect. Dis. 191:1686-1696.
29. McComsey, G. 2002. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy. AIDS Rev. 4:140-147.
30. McComsey, G., and J. F. Maa. 2003. Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy. AIDS Read. 13:539-542.
31. McComsey, G. A., D. M. Paulsen, J. T. Lonergan, S. M. Hessenthaler, C. L. Hoppel, V. C. Williams, R. L. Fisher, C. L. Cherry, C. White-Owen, K. A. Thompson, S. T. Ross, J. E. Hernandez, and L. L. Ross. 2005. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 19:15-23.
32. Miro, O., S. Lopez, M. Rodriguez de la Concepcion, E. Martinez, E. Pedrol, G. Garrabou, M. Giralt, F. Cardellach, J. M. Gatell, F. Vilarroya, and J. Casademont. 2004. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J. Acquir. Immune Defic. Syndr. 37:1550-1555.
33. Nolan, D., E. Hammond, I. James, E. McKinnon, and S. Mallal. 2003. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir. Ther. 8:617-626.
34. Nolan, D., E. Hammond, A. Martin, L. Taylor, S. Herrmann, E. McKinnon, C. Metcalf, B. Latham, and S. Mallal. 2003. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 17:1329-1338.
35. Nolan, D., and S. Mallal. 2004. Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms. Antivir. Ther. 9:849-863.
36. Nolan, D., and S. Mallal. 2004. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome. J. HIV Ther. 9:34-40.
37. Pace, C. S., A. M. Martin, E. L. Hammond, C. D. Mamotte, D. A. Nolan, and S. A. Mallal. 2003. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Antivir. Ther. 8:323-331.
38. Rustin, P., D. Chretien, T. Bourgeron, B. Gerard, A. Rotig, J. M. Saudubray, and A. Munnich. 1994. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228:35-51.
39. Scarpulla, R. C. 2002. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 1576:1-14.
40. Shikuma, C. M., N. Hu, C. Milne, F. Yost, C. Waslien, S. Shimizu, and B. Shiramizu. 2001. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 15:1801-1809.
41. Spelbrink, J. N., J. M. Toivonen, G. A. Hakkaart, J. M. Kurkela, H. M. Cooper, S. K. Lehtinen, N. Lecrenier, J. W. Back, D. Speijer, F. Foury, and H. T. Jacobs. 2000. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J. Biol. Chem. 275:24818-24828.
42. Stankov, M. V., T. Lucke, A. M. Das, R. E. Schmidt, and G. M. Behrens. 2007. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir. Ther. 12:205-216.
43. Sternberg, D., E. Chatzoglou, P. Laforet, G. Fayet, C. Jardel, P. Blondy, M. Fardeau, S. Amselem, B. Eymard, and A. Lombes. 2001. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain 124:984-994.
44. Tritschler, H. J., E. Bonilla, A. Lombès, F. Andreetta, S. Servidei, B. Schneyder, A. F. Miranda, E. A. Schon, B. Kadenbach, and S. DiMauro. 1991. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology 41:300-305.
45. van der Valk, M., M. Casula, G. J. Weverlingz, K. van Kuijk, B. van Eck-Smit, H. J. Hulsebosch, P. Nieuwkerk, A. van Eeden, K. Brinkman, J. Lange, A. de Ronde, and P. Reiss. 2004. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir. Ther. 9:385-393.
46. Viengchareun, S., M. Caron, M. Auclair, M. J. Kim, P. Frachon, J. Capeau, M. Lombes, and A. Lombes. 2007. Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes. Antivir. Ther. 12:919-929.
47. Villarroya, F., P. Domingo, and M. Giralt. 2005. Lipodystrophy associated with highly active antiretroviral therapy for HIV infection: the adipocyte as a target of antiretroviral-induced mitochondrial toxicity. Trends Pharmacol. Sci. 26:88-93.
48. Vittecoq, D., C. Jardel, C. Barthélémy, L. Escaut, N. Cheminot, S. Chapin, D. Sternberg, T. Maisonobe, and A. Lombès. 2002. Mitochondrial damage associated with long-term antiretroviral treatment: associated alteration or causal disorder? J. Acquir. Immune Defic. Syndr. 31:299-308.
49. Walker, U. A., M. Bickel, S. I. Lutke Volksbeck, U. P. Ketelsen, H. Schofer, B. Setzer, N. Venhoff, V. Rickerts, and S. Staszewski. 2002. Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. J. Acquir. Immune Defic. Syndr. 29:117-121.
50. Wilson-Fritch, L., A. Burkart, G. Bell, K. Mendelson, J. Leszyk, S. Nicoloro, M. Czech, and S. Corvera. 2003. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23:1085-1094.
51. Zhao, Q., J. Wang, I. V. Levichkin, S. Stasinopoulos, M. T. Ryan, and N. J. Hoogenraad. 2002. A mitochondrial specific stress response in mammalian cells. EMBO J. 21:4411-4419.